# Soy Protein/Effexor Hormone Therapy for Prostate Cancer

> **NCT00354432** · PHASE3 · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 120 (actual)

## Conditions studied

- Hot Flashes
- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** oral soy protein/isoflavones powder
- **DRUG:** Venlafaxine
- **DIETARY_SUPPLEMENT:** Placebo Powder
- **DRUG:** Placebo Pill

## Key facts

- **NCT ID:** NCT00354432
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02-01
- **Primary completion:** 2010-08-01
- **Final completion:** 2010-08-01
- **Target enrollment:** 120 (ACTUAL)
- **Why stopped:** Stopped by the DSMB for lack of effect per interim stopping rule.
- **Last updated:** 2021-09-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00354432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00354432, "Soy Protein/Effexor Hormone Therapy for Prostate Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00354432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*